US Patent 9938254 Antiproliferative compounds, and their pharmaceutical compositions and uses
Patent 9938254 was granted and assigned to Celgene on April, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9938254 Antiproliferative compounds, and their pharmaceutical compositions and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
